Bliss GVS Pharma
BLISSGVS · Pharma > Pharmaceuticals & Drugs · Chairman: S R Vaidya · MD: Gagan Harsh Sharma · Listing date: July 26, 2010 · Employees: 683 · Mumbai · http://www.blissgvs.com

Stock Price vs Company Growth
1d
0.4%
1w
9.1%
1m
6.2%
3m
7.7%
6m
0.3%
1y
48.9%
5y
6.3%
10y
9.7%
all
8.6%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 112 0.4%
101
142
Company Overview

Sales
770 Cr
Growth: 2.8%
Profit after Tax
75.5 Cr
Growth: -14.2%
Small Cap
1,177 Cr
P/E: 15.8x
Industry P/E: 34.5x
Fundamentals

Sales (Cr) ₹ 770
Growth 2.8%
EBITDA 19.6%
P/S 1.5x
Dividend 0.6%
P/E 15.8x
Book Value ₹ 1
PEG Ratio 5.7x
ROE 722.0%
P/B N/A
Shareholding Pattern

Institutions
Arian Investment Ltd
9.7 %
Life Insurance Corporation Of India
6.68 %
Polus Global Fund
4.62 %
Fidelity Puritan Trust-Fidelity Low-Priced Stock Fund
2.9 %
Aspire Emerging Fund
2.46 %
Promoters
Narsimha Shibroor Kamath
33.24 %
Others
Gulbarga Trading And Investment Pvt. Ltd.
5.67 %
Arjun Gautam Ashra
4.89 %
Gautam Rasiklal Ashra
2.82 %
Investor Education And Protection Fund Authority Ministry Of Corporate Affairs
2.2 %
Llp
0.05 %
Increase    Decrease    No change
Company Profile Detailed

It is a fast-growing Pharmaceutical Company with a proven track record of developing, manufacturing and marketing high quality pharmaceutical formulations at affordable prices for the global market. The company’s most unique product is ‘Today Vaginal Contraceptive’, a safe female contraceptive aimed at furthering Planned Parenthood and is also an established method for preventing conception.
Investors (61)
Followers (9)